Cutera's AviClearTM 12-Month Clinical Data Presented at the 42nd Annual Fall Clinical Dermatology Conference

Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that the 12-month clinical data related to AviClear, the first and only FDA-cleared energy-based device for the treatment of mild, moderate, and severe acne, was presented at the ...

Related Keywords

Nevada ,United States ,Brisbane ,Queensland ,Australia ,Michael Karavitis ,Margot Doucette ,Gary Goldenberg ,Amogh Kothare ,Valerie Callender ,Las Vegas ,Matteo Giuseppe Scopelliti ,Davidj Goldberg ,Regulatory Affairs ,Cutera Inc ,Nasdaq ,Annual Fall Clinical Dermatology Conference ,Medical Science ,Cosmetic Dermatology ,Hot In Acne ,Giuseppe Scopelliti ,Senior Biomedical Engineer ,Executive Vice President ,Chief Technology Officer ,Ashish Bhatia ,Harshdeep Kaur ,California Based Cutera ,Annual Fall Clinical Dermatology ,